Inactive Instrument

News PHARMING GROUP Euronext Amsterdam

Equities

NL0000377018

End-of-day quote Euronext Amsterdam Other stock markets
- ^EUR	-

22/04	Pharming Group to Buy Back EUR123 Million of Bonds due 2025	MT
18/04	Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K	25/04	PU
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards	25/04	AQ
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K	24/04	PU
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	24/04	PU
Pharming Group to report first quarter 2024 financial results on May 8	24/04	GL
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	24/04	GL
Pharming Group to Buy Back EUR123 Million of Bonds due 2025	22/04	MT
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025	19/04	GL
Pharming N : Pharming Group announces the placement of €100 million convertible bonds due 2029	19/04	PU
Pharming Group announces the placement of €100 million convertible bonds due 2029	18/04	GL
Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds	18/04	MT
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025	18/04	GL
Pharming Group N.V. announced that it expects to receive ?100 million in funding	18/04	CI
Pharming Group N.V. Announces Completion of Enrollment in Pediatric Clinical Trial of Leniolisib	08/04	CI
Pharming Group Finishes Enrolling Patients for Phase 3 Pediatric Testing of its Treatment for Rare Auto-Immune Disorder	08/04	MT
Pharming N : Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	08/04	PU
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	08/04	GL
Pharming N : Pharming Group announces the 2024 Annual General Meeting of Shareholders	04/04	PU
Pharming N : Pharming Group announces the filing of its 2023 Annual Report and Form 20-F	04/04	PU
Pharming N : Notice to Convene AGM 2024	04/04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PHARMING GROUP Euronext Amsterdam

Equities

NL0000377018

Summary

Filters